alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### § 1.118-1 Contributions to the capital of a corporation.

In the case of a corporation, section 118 provides an exclusion from gross income with respect to any contribution of money or property to the capital of the taxpayer. Thus, if a corporation requires additional funds for conducting its business and obtains such funds through voluntary pro rata payments by its shareholders, the amounts so received being credited to its surplus account or to a special account, such amounts do not constitute income, although there is no increase in the outstanding shares of stock of the corporation. In such a case the payments are in the nature of assessments upon, and represent an additional price paid for, the shares of stock held by the individual shareholders, and will be treated as an addition to and as a part of the operating capital of the company. Section 118 also applies to contributions to capital made by persons other than shareholders. For example, the exclusion applies to the value of land or other property contributed to a corporation by a governmental unit or by a civic group for the purpose of inducing the corporation to locate its business in a particular community, or for the purpose of enabling the corporation to expand its operating facilities. However, the exclusion does not apply to any money or property transferred to the corporation in consideration for goods or services rendered, or to subsidies paid for the purpose of inducing the taxpayer to limit production. See section 362 for the basis of property acquired by a corporation through a contribution to its capital by its stockholders or by nonstockholders.
Pursuant to Ind. Appellate Rule 65(D), this 

Memorandum Decision shall not be 

regarded as precedent or cited before any 

court except for the purpose of establishing 

the defense of res judicata, collateral 

estoppel, or the law of the case.

ATTORNEY FOR APPELLANT: ATTORNEYS FOR APPELLEE:

JEFFREY E. STRATMAN GREGORY F. ZOELLER

Aurora, Indiana Attorney General of Indiana

J.T. WHITEHEAD

Deputy Attorney General

Indianapolis, Indiana

IN THE

COURT OF APPEALS OF INDIANA

B.C., )

)

Appellant-Respondent, )

)

vs. ) No. 15A01-1202-JV-68

)

STATE OF INDIANA, )

)

Appellee-Petitioner. )

APPEAL FROM THE DEARBORN CIRCUIT COURT 

The Honorable James D. Humphrey, Judge 

Cause No. 15C01-0805-JD-102 and 15C01-0806-JD-103

August 31, 2012

 

MEMORANDUM DECISION - NOT FOR PUBLICATION

KIRSCH, Judge 
2

B.C. appeals the trial court’s order requiring him to register as a sex offender 

contending that the order was premature and was not supported by clear and convincing 

evidence. The State concedes that the order is premature and should be vacated. A sex 

offender registry hearing for a juvenile may be conducted only after the juvenile has been 

released from a juvenile detention facility or discharged from a secure private facility. B.W. 

v. State, 909 N.E.2d 471, 477 (Ind. Ct. App. 2009). Here, the trial court ordered B.C. placed 

in Wernle Children’s facility, a secure private facility. He has not been released from the 

facility, and the trial court order is premature. We vacate the trial court’s registration order 

and remand with instructions.

Vacated and remanded. 

NAJAM, J., and MAY, J., concur.
Editorial Note on Part 892
Editorial Note: Nomenclature changes to part 892 appear at 73 FR 35341, June 23, 2008.

§ 892.1390 Radionuclide rebreathing system. ( a ) *Identification.* A radionuclide rebreathing system is a device intended to be used to contain a gaseous or volatile radionuclide or a radionuclide-labeled aerosol and permit it to be respired by the patient during nuclear medicine ventilatory tests (testing process of exchange between the lungs and the atmosphere). This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.
( b ) *Classification.* Class II.
<TABLE> <S> <C>


<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               JUN-30-1997
<CASH>                                       5,263,185
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0<F1>
<PP&E>                                     416,223,360
<DEPRECIATION>                              19,315,189
<TOTAL-ASSETS>                             409,465,480
<CURRENT-LIABILITIES>                                0<F1>
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                   335,509,830
<OTHER-SE>                                (27,299,134)
<TOTAL-LIABILITY-AND-EQUITY>               409,465,480
<SALES>                                              0
<TOTAL-REVENUES>                            31,876,837
<CGS>                                                0
<TOTAL-COSTS>                               21,459,213
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,893,126
<INCOME-PRETAX>                              8,531,044
<INCOME-TAX>                                         0<F2>
<INCOME-CONTINUING>                          8,531,044
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 8,531,044
<EPS-PRIMARY>                                     0.28
<EPS-DILUTED>                                        0
<FN>
<F1>Current Assets and Current Liabilities are not separated to conform
with industry standards.
<F2>Income is from rental income. There are no Sales or Cost of Goods
Sold.
</FN>
        




</TABLE>
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.2440 Automated medium dispensing and stacking device. ( a ) *Identification.* An automated medium dispensing and stacking device is a device intended for medical purposes to dispense a microbiological culture medium into petri dishes and then mechanically stack the petri dishes.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9. The device is also exempt from the good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[47 FR 50823, Nov. 9, 1982, as amended at 66 FR 38791, July 25, 2001]
Editorial Note on Part 892
Editorial Note: Nomenclature changes to part 892 appear at 73 FR 35341, June 23, 2008.

§ 892.5740 Radionuclide teletherapy source. ( a ) *Identification.* A radionuclide teletherapy source is a device consisting of a radionuclide enclosed in a sealed container. The device is intended for radiation therapy, with the radiation source located at a distance from the patient's body.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 892.9.
[53 FR 1567, Jan. 20, 1988, as amended at 59 FR 63015, Dec. 7, 1994; 66 FR 38819, July 25, 2001]
<PAGE>
                                                                    EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Advanced Marketing
Services, Inc. (the "Company") for the quarter ended June 29, 2002 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Edward J. Leonard, Executive Vice President and Chief Financial Officer of the
Company, certify, pursuant to and for purposes of 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1)   The Report fully complies with the requirements of section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      (2)   The information contained in the Report fairly presents, in all
            material respects, the financial condition of the Company as of the
            dates indicated and results of operations of the Company for the
            periods indicated.




                                        /s/ EDWARD J. LEONARD
                                        ---------------------------------
                                        Edward J. Leonard
                                        Executive Vice President and
                                          Chief Financial Officer
                                        August 12, 2002
October 7, 2002

Assignment agreement between First Goldwater Resources Inc. ("Goldwater") and
Micron Enviro Systems Inc. ("Micron").

This agreement shall outline the terms and conditions of the assignment of a 5%
working interest and a 3.875% net revenue interest in the 12-10 Well located in
Kern County, California more specifically described as the Pioneer Canal area of
the Canal Oil field located in Township 30 South Range 25 East, Sections 3, 4,
9, 10.

Goldwater warrants that it is the owner of 37.325% of the 12-10 Well and it is
desiring to assign to Micron a 5% Working interest and a 3.875% net revenue
interest for a price of $2,500 US. Goldwater further acknowledges that that the
rights being assigned include the Pulv and Olcese Prospects as outlined in the
Vaughan Production Co. & Vaughan Exploration, Inc. report dated August 4, 1999
attached as exhibit "A".

Micron acknowledges that the interest in the 12-10 Well is subject to a non
consent clause relating to a rework of the well dated on or about May 22, 2002.
This rework was done at a cost of approximately $70,000 US and Micron will see
no revenue from the 12-10 Well until the well has paid out $280,000 US.






Agreed and accepted by:                       Agreed and accepted by:





/s/ Graeme Sewell                             /s/ Bernard McDougall
------------------------------                ------------------------------
First Goldwater Resources Inc.                Micron Enviro Systems Inc.

Dated  October 8, 2002                        Dated  October 8, 2002
     -------------------------                     -------------------------
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.3240 Cholinesterase test system. ( a ) *Identification.* A cholinesterase test system is a device intended to measure cholinesterase (an enzyme that catalyzes the hydrolysis of acetylcholine to choline) in human specimens. There are two principal types of cholinesterase in human tissues. True cholinesterase is present at nerve endings and in erythrocytes (red blood cells) but is not present in plasma. Pseudo cholinesterase is present in plasma and liver but is not present in erythrocytes. Measurements obtained by this device are used in the diagnosis and treatment of cholinesterase inhibition disorders (e.g., insecticide poisoning and succinylcholine poisoning).
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
[52 FR 16122, May 1, 1987, as amended at 84 FR 71797, Dec. 30, 2019]
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.1620 Intracranial pressure monitoring device. ( a ) *Identification.* An intracranial pressure monitoring device is a device used for short-term monitoring and recording of intracranial pressures and pressure trends. The device includes the transducer, monitor, and interconnecting hardware.
( b ) *Classification.* Class II (performance standards).
### SAT Report PMN Number: P-15-0188 SAT Date: 1/27/2015 Print Date: 5/8/2015

Related cases : Yes Health related cases: Ecotox related cases:

Concern levels : Type of Concern: Health Eco Comments Level of Concern: 1-2 3

Persistence Bioaccum Toxicity Comments 3 11

Exposure Based Review : Health: Ecotox: N o
Routes of exposure : Health: Dermal Drinking Water Inhalation Ecotox: All releases to water Fate: ; Keywords : Keywords: AQUATOX; IRR; MUTA; SENS
Summary of Assessment :
Fate : Fate Summary: P-15-0188 FATE: Liquid with MP < 25 C (E) S = 0.16 mg/L at 25 °C (E) VP < 1.0E-6 torr at 25 C (E) BP > 400 C (E) H < 1.00E-8 (E) POTW removal (%) = 90 via sorption Time for complete ultimate aerobic biodeg > mo Sorption to soils/sediments = v.strongPBT Potential: P3B1 *CEB FATE: Migration to ground water = negl

Health : Health Summary: Absorption is poor all routes (analogue). There is uncertain concern for irritation and concern for mutagenicity and sensitization based on the methacrylate moiety.

Ecotox :
Test Organism Test Type Test End Point Predicted Measured Comments

fish 96-h LC50 0.96 or * daphnid 48-h LC50 0.88 or * green algal 96-h EC50 0.20 fish

_ chronic value 0.071 daphnid

_ chronic value 0.10
algal

_ chronic value 0.11
Sewage Sludge 3-h EC50 Sewage Sludge

_ Chronic Value _

Ecotox Values Comments: Predictions are based on SARs for methacrylates; SAR chemical class = methacrylate; MW liquid with unknown mp (P); log Kow = 5.07 (EPI, n=0); S = 0.16 mg/L at 20 C (P, n=0); p H7; effective concentrations based on 100% active ingredients and mean measured concentrations; hardness <150.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments Assessment Factor 10 Concentration of Concern ( p pb) Acute Concentration of Concern ( p pb) Chronic 7

SARs methacrylates SAR Class methacrylate N ew Chemcial Category Acrylates/Methacrylates

Ecotox Factors Comments:

SAT Chair:
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 By Notice dated October 21, 2009, and published in the 
                    **Federal Register**
                     on October 28, 2009, (74 FR 55588), Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066-1742, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug
ScheduleGamma Hydroxybutyric Acid (2010)
ITetrahydrocannabinols (7370)
IDihydromorphine (9145)
IDifenoxin (9168)
IPropiram (9649)
IAmphetamine (1100)
IIMethamphetamine (1105)
IILisdexamfetamine (1205)
IIMethylphenidate (1724)
IINabilone (7379)
IICocaine (9041)
IICodeine (9050)
IIDihydrocodeine (9120)
IIOxycodone (9143)
IIHydromorphone (9150)
IIEcgonine (9180)
IIHydrocodone (9193)
IIMeperidine (9230)
IIMethadone (9250)
IIMethadone intermediate (9254)
IIMorphine (9300)
IIThebaine (9333)
IIOxymorphone (9652)
IINoroxymorphone (9668)
IIAlfentanil (9737)
IIRemifentanil (9739)
IISufentanil (9740)
IIFentanyl (9801)
II
 The company plans to manufacture the listed controlled substances in bulk for sale to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Johnson Matthey Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: February 24, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2010-4404 Filed 3-2-10; 8:45 am] BILLING CODE 4410-09-P
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.2850 Automated zone reader. ( a ) *Identification.* An automated zone reader is a mechanical device intended for medical purposes to measure zone diameters of microbial growth inhibition (or exhibition), such as those observed on the surface of certain culture media used in disc-agar diffusion antimicrobial susceptibility tests. The device aids in decisionmaking respecting the treatment of disease.
( b ) *Classification.* Class I (general controls).
## 'OERARTMEWTD F TRANSPORWIO N ^•OCKE I OPER/^ION S 201 0 OC T- U Aq:.2. 5 801 Sout h Victori a Avcnun.Siiil

o 20 0 Vfinliira . Californi

a 9300 3 VAW/.vcnliiracliainbBr.coni » 805.676.750 0 » ra,x : 805.650.111 1 Augus t 24 . 201 0 Th e Honorabl e Ra yLaHoo d Secretary Unite d State s Depailmen l of Transportatio n 120 0 Ne wJerse yAve . S E Washingto n D.C . Dea rSecretaryLaHood : Thi s lette ri s sen t t o yo u t o indicat e th e Ventur a Chambe ro f Commerce' s support o f th e applicatio n o f Ventur a County/Oxnar d Airpor t fo ra gran t i n th e 201 0 Smal l Communit y Ai rServic e Developmen t Program . Th e gran t requeste d i s $520,00 0 wit h a loca l contributio n an d ticke t purchas e progra m o f $480,00 0 a s a n incentiv e fo rne wai rservic e a t Oxnar d Airport . Th e Oxnar d Airpor t ha s ha d continuou s passenge rai rservic e sinc e 194 6 and . unfortunately , Unite d Expres s terminate d it s schedule d ai rservic e o n Jun e 8" ^ o f thi s yea rleavin g Oxnar d Airpor t wit h n o ai rservice . Th e los s o f ai rservic e ha s a significan t impact o n ou rbusiness . Ou ronl yoptio n i s t o no wdriv e t o eithe rBurban k Airport o rLo s Angele s Internationa l Airport . Th e driv e o n th e freeway s fro m Ventur a Count yi s lon g an d verycongested . I t ca n easil ytak e ove rtw o hour s t o ge t t o eithe rairport . I understan d tha t Ventur a Count yDepartmen t o f Airport s managemen t ha s ha d meetin g wit h Horizo n Ai rabou t providin g nonsto p servic e t o Sa n Jos e wit h flight s continuin g o n t o it s market s i n th e Pacifi cNorthwest . W e ar e i n suppor t o f thi s typ e of ai rservic e an d wil l b e a n importan t lin k

t o market s i n th e nort h an d connection s t o othe rareas . W e believ e tha t i f Horizo n Ai ri s successfu l a t Oxnar d Airport . Horizo n wil l ad d mor e flight s t o othe r market s o rothe rairline s wil l com e t o ou rairpor t wit h nonsto p servic e t o othe rregiona l hu b airports . Ou rcommunit yneed s ai rservic e a t Oxnar d Airpor t an d thi s wil l b e a goo d start . I strongl ysupport th e applicatio n o f Ventur a County/Oxnar d Airpor t fo ra gran t unde rthi s progra m an d wil l support th e ne wai rservice . Sincerely , Sandr a M , Walke r Presiden t an d CE O Ventur a Chambe ro f Commerc e

l\ilission Statemen

t T o promot e qualit yo t lif e through economi

c vitality "
I 

118TH CONGRESS 

2D SESSION H. R. 7905 

To prohibit States from imposing a tax on the retail sale of menstrual 

products. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 9, 2024 

Mr. GREEN of Texas (for himself, Ms. MENG, Ms. ADAMS, Mrs. BEATTY, Mr. 

BOWMAN, Mr. CARSON, Mr. CASTEN, Mrs. CHERFILUS-MCCORMICK, Ms. 

CHU, Ms. CLARKE of New York, Mr. CONNOLLY, Ms. ESCOBAR, Mrs. 

FOUSHEE, Ms. LOIS FRANKEL of Florida, Ms. GARCIA of Texas, Mr. 

GOTTHEIMER, Mr. GRIJALVA, Ms. NORTON, Ms. JACKSON LEE, Ms. LEE

of Pennsylvania, Ms. LEE of California, Ms. MOORE of Wisconsin, Mr. 

MULLIN, Mr. NADLER, Mrs. NAPOLITANO, Ms. PETTERSEN, Ms. ROSS, 

Mr. RUIZ, Ms. SALINAS, Ms. SCHAKOWSKY, Ms. SEWELL, Ms. TLAIB, 

Mrs. TORRES of California, Ms. WILSON of Florida, and Mr. SWALWELL) 

introduced the following bill; which was referred to the Committee on the 

Judiciary 

A BILL 

To prohibit States from imposing a tax on the retail sale 

of menstrual products. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Stop Taxes Against 

5 Menstrual Products Act of 2024’’ or the ‘‘STAMP Act 

6 of 2024’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7905 IH

1 SEC. 2. PROHIBITION. 

2 It shall be unlawful for a State, or unit of local gov3 ernment of a State, to impose a tax on the retail sale of 

4 a menstrual product. 

5 SEC. 3. DEFINITIONS. 

6 For purposes of this Act: 

7 (1) MENSTRUAL PRODUCT.—The term ‘‘men8 strual product’’ means a sanitary napkin, or tam9 pon, menstrual cups, menstrual discs, period under10 wear, and that conforms to industry standards. 

11 (2) STATE.—The term ‘‘State’’ means any of 

12 the several States or the District of Columbia. 

13 SEC. 4. EFFECTIVE DATE. 

14 This Act shall take effect 120 days after the date of 

15 the enactment of this Act. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.5970 Percutaneous, implanted, long-term intravascular catheter. ( a ) *Identification.* A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.
( b ) *Classification.* Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.”
[65 FR 37043, June 13, 2000]